Papers: 27 Feb 2015 - 6 Mar 2015
"Liberation treatment" for chronic cerebrospinal venous insufficiency in multiple sclerosis: the truth will set you free.
Evaluation of the effects of group psychotherapy on cognitive function in patients with multiple sclerosis with cognitive dysfunction and depression.
Effects of balance-specific exercises on balance, physical activity and quality of life in adults with multiple sclerosis: a pilot investigation.
Control of IL-17 receptor signaling and tissue inflammation by the p38α-MKP-1 signaling axis in a mouse model of multiple sclerosis.
Endogenous Interferon-β-Inducible Gene Expression and Interferon-β-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis.
Implications for multiple sclerosis in the era of the Affordable Care Act: the shifting managed care landscape.
FTY720 (fingolimod) treatment tips the balance towards less immunogenic antigen-presenting cells in patients with multiple sclerosis.
Implications for multiple sclerosis in the era of the Affordable Care Act: an evolving treatment paradigm.
Vitamin D3 influence the Th1/Th2 ratio in C57BL/6 induced model of experimental autoimmune encephalomyelitis.
Multiple sclerosis: Biomarkers predict conversion from clinically isolated syndrome to multiple sclerosis.
Urodynamic changes in mice with experimental autoimmune encephalomyelitis correlate with neurological impairment.
DOPAMINE AND T CELLS: Receptors, Direct and Potent Effects, Endogenous Production and Abnormalities in Autoimmune, Neurological and Psychiatric Diseases.
Evaluating Neurocognitive Deficits in Patients with Multiple Sclerosis via a Brief Neuropsychological Approach.
Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.
Perceived Cognitive Difficulties and Cognitive Test Performance as Predictors of Employment Outcomes in People with Multiple Sclerosis.
Dimethyl fumarate attenuates cerebral edema formation by protecting the blood-brain barrier integrity.
Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.
Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation.
No Overlap among Serum GAD65, NMDAR and AQP4 Antibodies in Patients with Neuromyelitis Optica Spectrum Disorders.
Dimethyl fumarate suppresses Theiler's murine encephalomyelitis virus - induced demyelinating disease by modifying Nrf2-Keap1 pathway.
A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis.
Diazepam Inhibits Proliferation of Lymph Node Cells Isolated from Rats with Experimental Autoimmune Encephalomyelitis.
Effects of a Tailored Positive Psychology Intervention on Well-being and Pain in Individuals with Chronic Pain and a Physical Disability: A Feasibility Trial.
Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis.
Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial.
Effect of a self-management and follow-up program on self-efficacy in patients with multiple sclerosis: a randomized clinical trial.